Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
ClinicalTrials.gov study NCT01097057. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03210662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma
ClinicalTrials.gov study NCT04160195. IPD Sharing: YES. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00002471. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01075321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01812005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT00337194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT02509039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
ClinicalTrials.gov study NCT04359784. IPD Sharing: NO. Countries: 1. Publications: 0.
Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03035331. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines
ClinicalTrials.gov study NCT00001571. IPD Sharing: Not stated. Countries: 1. Publications: 3.
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00787527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00193492. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03739619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03488251. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT05216835. IPD Sharing: YES. Countries: 7. Publications: 0.
Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01408043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01281917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).
ClinicalTrials.gov study NCT00741325. IPD Sharing: Not stated. Countries: 0. Publications: 1.
CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04217317. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.